The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The measure lowers prescription drug costs for seniors by empowering Medicare to negotiate the cost of prescription drugs. The negotiated prices include:

A report breaks down the Trump administration’s push for lower Medicare drug prices while lawmakers clash over whether to extend COVID-era insurance subsidies set to expire January 1.